EFFECT OF DRUGS ON POSTOPERATIVE INFLAMMATORY MARKERS AFTER SINGLE VALVE REPLACEMENT SURGERY
Not Applicable
- Conditions
- Health Condition 1: I342- Nonrheumatic mitral (valve) stenosis
- Registration Number
- CTRI/2021/01/030408
- Lead Sponsor
- Dr RAJESHWAR ZALA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ADULTS PATIENTS AGED 18 TO 70 YEARS, AMERICAN SOCIETY OF ANAESTHESIOLOGISTS (ASA) GRADE I,II,III.,BMI <28KG/M2, PATIENTS WHO COMPLIED WITH SURGICAL INDICATION FOR SINGLE VALVE REPLACEMENT SURGERY, EJECTION FRACTION - 60% OR MORE.
Exclusion Criteria
H/O FEVER IN LAST TWO WEEKS, TLC >11000 (PRE-EXISTING INFECTION), NSAIDS AND PREOPERATIVE STEROIDS BEFORE 2 WEEKS OF SURGERY, ALLERGY TO STUDY DRUGS, NEUROLOGICAL OR PSYCHIATRIC DISEASE, HEPATIC DISEASE, SEVERE RENAL INSUFFICIENCY, RESPIRATORY DISEASE
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO COMPARE THE EFFECTS OF IV DEXMEDETOMIDINE ON SERUM PROCALCITONIN LEVELS VERSUS CONTROL GROUP IN SINGLE VALVE REPLACEMENT SURGERY DONE ON CARDIOPULMONARY BYPASSTimepoint: FROM INDUCTION TO 72 HRS POST OPERATIVELY
- Secondary Outcome Measures
Name Time Method HEMODYNAMIC VARIABLES, BODY TEMPERATURE, COMPLETE BLOOD COUNT, ADVERSE EFFECTS LIKE NAUSEA, VOMITING, DROWSINESS, HYPOTENSION, BRADYCARDIA, RESPIRATORY DEPRESSION, PRURITUSTimepoint: FROM INDUCTION TO 72 HRS POST OPERATIVELY